|
WO2020164721A1
|
|
Chromatographic purification of at least one enzyme selected from the group consisting of collagenase type i, neutral protease, and clostripain
|
|
DE102017104472A1
|
|
Orodispersible tablet containing burlulipase and pharmaceutical composition prepared therefrom
|
|
DE102017104482A1
|
|
A pharmaceutical composition comprising pancreatin and a lipase-containing coating
|
|
DE102017104501A1
|
|
A pharmaceutical composition comprising a carrier and a coating containing at least one lipase
|
|
DE102017104480A1
|
|
Aqueous solution of burlulipase comprising calcium ions
|
|
DE102015119006A1
|
|
Method for reducing the burden of pancreatin on microorganisms
|
|
DE102015114859A1
|
|
Use of a pharmaceutical composition containing at least one digestive enzyme in artificial nutrition
|
|
DE102015114862A1
|
|
Pharmaceutical composition containing a bacterial lipase
|
|
DE102015114857A1
|
|
Beverage containing a pharmaceutical composition
|
|
JP2014193909A
|
|
Pharmaceutical preparation
|
|
EP2489349A2
|
|
Pancreatin pellets, in particular pancreatin micropellets and method for producing same
|
|
EP2295039A1
|
|
Method of preparing pancreatin pellets, in particular pancreatin micropellets, and pancreatin pellets prepared thereby
|
|
CN106139132A
|
|
Pharmaceutical preparation comprising lipase of bacterial origin
|
|
EP2295086A1
|
|
Method of reducing the viral and microbial load of pancreatin
|
